## Abstract Oncogenic transformation in human and experimental animals is not necessarily followed by the appearance of a tumor mass. The immune system of the host can recognize tumor antigens by the presentation of small antigenic peptides to the receptor of cytotoxic Tβlymphocytes (CTLs) and reje
MHC antigens and non-immune functions
β Scribed by Michael Edidin
- Book ID
- 103582446
- Publisher
- Elsevier Science
- Year
- 1983
- Tongue
- English
- Weight
- 217 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0167-5699
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Basic biochemical techniques have been skillfully used to characterize MHC-bound peptides and to examine the changes that occur in MHC molecules and lymphocyte membrane receptor complexes upon ligand binding. The fine tuning of these experimental approaches was possible because of the availability o
Besides their "classical" antigenic peptide-presenting activity, major histocompatibility complex (MHC) class II antigens can activate different cellular functions in immune and nonimmune cells. However, this "nonclassical" role and its functional consequences are still substantially overlooked. In
neonatal Fc receptor IFN-Ξ³ Ξ³ interferon Ξ³ ILT immunoglobulin-like transcript MIC MHC class I